Skip to main content
Erschienen in: International Journal of Legal Medicine 2/2017

09.12.2016 | Original Article

Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism

verfasst von: Francesco Brandimarti, Federica Alessandrini, Mauro Pesaresi, Chiara Catalani, Letizia De Angelis, Roberta Galeazzi, Simona Giovagnetti, Rosaria Gesuita, Elisa Righi, Raffaele Giorgetti, Adriano Tagliabracci

Erschienen in: International Journal of Legal Medicine | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Venous thromboembolism (VTE) is a multifactorial disease determined by a combination of inherited and acquired factors. Inherited factors include mutations in the genes coding for coagulation factors, some of which seem to exert a differential influence on the risk of developing deep vein thrombosis (DVT) and pulmonary embolism (PE). In post-mortem studies of subjects who have died from pulmonary embolism (PE), the analysis of the factors that may have augmented the VTE risk is often limited to acquired factors. This is due to the complexity—and sometimes the unfeasibility—of analyzing genetic factors and to insufficient knowledge of their individual roles in PE development. The present study used formalin-fixed paraffin-embedded (FFPE) tissue to investigate a panel of 12 polymorphisms—the largest ever studied—that affect the VTE risk. Tissue samples came from post-mortem examinations performed by the specialists of the Section of Legal Medicine of the Department of Pathology of Marche’s Polytechnic University, and by the specialists of Health Care District Hospital of Imola, on 44 subjects who died from PE in the period 1997–2014. All individuals were found to have at least one mutation affecting the VTE risk. The present study demonstrates that genetic analysis can be performed post-mortem and the results are useful for forensic investigations, especially from MTHFR C677T and PAI-1 4G/5G polymorphisms. Broader studies using the techniques described herein are needed to determine the relative influence of the individual polymorphisms and their interaction in PE deaths.
Literatur
1.
Zurück zum Zitat Mäkelburg AB, Veeger NJ, Middeldorp S, Hamulyák K, Prins MH, Büller HR, Lijfering WM (2010) Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study. Haematologica 95(6):1030–1033CrossRefPubMed Mäkelburg AB, Veeger NJ, Middeldorp S, Hamulyák K, Prins MH, Büller HR, Lijfering WM (2010) Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study. Haematologica 95(6):1030–1033CrossRefPubMed
2.
Zurück zum Zitat Bounameaux H (2000) Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism. Lancet 356(9225):182–183CrossRefPubMed Bounameaux H (2000) Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism. Lancet 356(9225):182–183CrossRefPubMed
3.
Zurück zum Zitat Kuismanen K, Savontaus ML, Kozlov A, Vuorio AF, Sajantila A (1999) Coagulation factor V Leiden mutation in sudden fatal pulmonary embolism and in a general northern European population sample. Forensic Sci Int 106(2):71–75CrossRefPubMed Kuismanen K, Savontaus ML, Kozlov A, Vuorio AF, Sajantila A (1999) Coagulation factor V Leiden mutation in sudden fatal pulmonary embolism and in a general northern European population sample. Forensic Sci Int 106(2):71–75CrossRefPubMed
4.
Zurück zum Zitat Vandenbroucke JP, Bertina RM, Holmes ZR, Spaargaren C, van Krieken JH, Manten B, Reitsma PH (1998) Factor V Leiden and fatal pulmonary embolism. Thromb Haemost 79(3):511–516PubMed Vandenbroucke JP, Bertina RM, Holmes ZR, Spaargaren C, van Krieken JH, Manten B, Reitsma PH (1998) Factor V Leiden and fatal pulmonary embolism. Thromb Haemost 79(3):511–516PubMed
5.
Zurück zum Zitat Ameziane N, Seguin C, Borgel D, Fumeron F, Moatti D, Alhenc-Gelas M, Grandchamp B, Aiach M, Emmerich J, de Prost D (2002) The −33T → C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations. Thromb Haemost 88(2):195–199PubMed Ameziane N, Seguin C, Borgel D, Fumeron F, Moatti D, Alhenc-Gelas M, Grandchamp B, Aiach M, Emmerich J, de Prost D (2002) The −33T → C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations. Thromb Haemost 88(2):195–199PubMed
6.
Zurück zum Zitat Fineschi V, Bafunno V, Bello S, De Stefano F, Margaglione M, Neri M, Riezzo I, Turillazzi E, Bonsignore A, Vecchione G, Ventura F, Grandone E (2012) Fatal pulmonary thromboembolism. A retrospective autopsy study: searching for genetic thrombophilias (factor V Leiden (G1691A) and FII (G20210A) gene variants) and dating the thrombus. Forensic Sci Int 214(1–3):152–158PubMed Fineschi V, Bafunno V, Bello S, De Stefano F, Margaglione M, Neri M, Riezzo I, Turillazzi E, Bonsignore A, Vecchione G, Ventura F, Grandone E (2012) Fatal pulmonary thromboembolism. A retrospective autopsy study: searching for genetic thrombophilias (factor V Leiden (G1691A) and FII (G20210A) gene variants) and dating the thrombus. Forensic Sci Int 214(1–3):152–158PubMed
7.
Zurück zum Zitat Gohil R, Peck G, Sharma P (2009) The genetics of venous thromboembolism. A meta-analysis involving approximately 120, 000 cases and 180, 000 controls. Thromb Haemost 102(2):360–370PubMed Gohil R, Peck G, Sharma P (2009) The genetics of venous thromboembolism. A meta-analysis involving approximately 120, 000 cases and 180, 000 controls. Thromb Haemost 102(2):360–370PubMed
8.
Zurück zum Zitat Luyendyk JP, Tilley RE, Mackman N (2006) Genetic susceptibility to thrombosis. Curr Atheroscler Rep 8(3):193–197CrossRefPubMed Luyendyk JP, Tilley RE, Mackman N (2006) Genetic susceptibility to thrombosis. Curr Atheroscler Rep 8(3):193–197CrossRefPubMed
9.
Zurück zum Zitat Skretting G, Stavik B, Landvik NE, Myklebust CF, Iversen N, Zienolddiny S, Sandset PM (2010) Functional characterization of polymorphisms in the human TFPI gene. Biochem Biophys Res Commun 397(1):106–111CrossRefPubMed Skretting G, Stavik B, Landvik NE, Myklebust CF, Iversen N, Zienolddiny S, Sandset PM (2010) Functional characterization of polymorphisms in the human TFPI gene. Biochem Biophys Res Commun 397(1):106–111CrossRefPubMed
10.
Zurück zum Zitat Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M, Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35(43):3033–3069 3069a-3069kCrossRefPubMed Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M, Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35(43):3033–3069 3069a-3069kCrossRefPubMed
11.
Zurück zum Zitat Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107(8):1117–1122CrossRef Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107(8):1117–1122CrossRef
12.
Zurück zum Zitat Zappacosta B, Romano L, Persichilli S, Cutrone LA, Graziano M, Vitrani A, Di Castelnuovo A, Giardina B, Musumeci S, Mastroiacovo P (2009) Genotype prevalence and allele frequencies of 5, 10-methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in Italian newborns. Lab Medicine 40(12):732–736CrossRef Zappacosta B, Romano L, Persichilli S, Cutrone LA, Graziano M, Vitrani A, Di Castelnuovo A, Giardina B, Musumeci S, Mastroiacovo P (2009) Genotype prevalence and allele frequencies of 5, 10-methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in Italian newborns. Lab Medicine 40(12):732–736CrossRef
13.
Zurück zum Zitat Faioni EM, Castaman G, Asti D, Lussana F, Rodeghiero F (2004) Association of factor V deficiency with factor V HR2. Haematologica 89(2):195–200PubMed Faioni EM, Castaman G, Asti D, Lussana F, Rodeghiero F (2004) Association of factor V deficiency with factor V HR2. Haematologica 89(2):195–200PubMed
14.
Zurück zum Zitat Menegatti M, Asselta R, Duga S, Malcovati M, Bucciarelli P, Mannucci PM, Tenchini ML (2001) Identification of four novel polymorphisms in the Aalpha and gamma fibrinogen genes and analysis of association with plasma levels of the protein. Thromb Res 103(4):299–307CrossRefPubMed Menegatti M, Asselta R, Duga S, Malcovati M, Bucciarelli P, Mannucci PM, Tenchini ML (2001) Identification of four novel polymorphisms in the Aalpha and gamma fibrinogen genes and analysis of association with plasma levels of the protein. Thromb Res 103(4):299–307CrossRefPubMed
15.
Zurück zum Zitat Saibeni S, Vecchi M, Faioni EM, Franchi F, Rondonotti E, Borsi G, de Franchis R (2003) Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease. Dig Liver Dis 35(1):32–36CrossRefPubMed Saibeni S, Vecchi M, Faioni EM, Franchi F, Rondonotti E, Borsi G, de Franchis R (2003) Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease. Dig Liver Dis 35(1):32–36CrossRefPubMed
16.
Zurück zum Zitat Abbate R, Marcucci R, Camacho-Vanegas O, Pepe G, Gori AM, Capanni M, Simonetti I, Prisco D, Gensini GF (1998) Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 82(4):524–525CrossRefPubMed Abbate R, Marcucci R, Camacho-Vanegas O, Pepe G, Gori AM, Capanni M, Simonetti I, Prisco D, Gensini GF (1998) Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 82(4):524–525CrossRefPubMed
17.
Zurück zum Zitat Opstad TB, Pettersen AA, Weiss T, Arnesen H, Seljeflot I (2010) Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes. Thromb J 8:7CrossRefPubMedPubMedCentral Opstad TB, Pettersen AA, Weiss T, Arnesen H, Seljeflot I (2010) Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes. Thromb J 8:7CrossRefPubMedPubMedCentral
Metadaten
Titel
Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism
verfasst von
Francesco Brandimarti
Federica Alessandrini
Mauro Pesaresi
Chiara Catalani
Letizia De Angelis
Roberta Galeazzi
Simona Giovagnetti
Rosaria Gesuita
Elisa Righi
Raffaele Giorgetti
Adriano Tagliabracci
Publikationsdatum
09.12.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Legal Medicine / Ausgabe 2/2017
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-016-1508-z

Weitere Artikel der Ausgabe 2/2017

International Journal of Legal Medicine 2/2017 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin